Literature DB >> 28558089

Analysis of Heart Rate Variability Before and During Tilt Test in Patients with Cardioinhibitory Vasovagal Syncope.

Cláudia Madeira Miranda1, Rose Mary Ferreira Lisboa da Silva2.   

Abstract

BACKGROUND: Cardioinhibitory vasovagal response is uncommon during the tilt test (TT). Heart rate variability (HRV) by use of spectral analysis can distinguish patients with that response.
OBJECTIVE: To compare the HRV in patients with cardioinhibitory vasovagal syncope (case group - G1) with that in patients without syncope and with negative response to TT (control group - G2).
METHODS: 64 patients were evaluated (mean age, 36.2 years; 35 men) and submitted to TT at 70 degrees, under digital Holter monitoring. The groups were paired for age and sex (G1, 40 patients; G2, 24).
RESULTS: In G1, 21 patients had a type 2A response and 19 had type 2B, with mean TT duration of 20.4 minutes. There was a greater low frequency (LF) component (11,6 versus 4,5 ms2, p=0.001) and a lower low/high frequency ratio in the supine position (3,9 versus 4,5 ms2, p=0.008) in G1, with no difference during TT between the groups. Applying the receiver operating characteristic curve for cardioinhibitory response, the area under the curve was 0.74 for the LF component in the supine position (p = 0.001). The following were observed for the cutoff point of 0.35 ms(2) for the LF component: sensitivity, 97.4%; specificity, 83.3%; positive predictive value, 85.3%; negative predictive value, 96.9%; and positive likelihood ratio, 5.8.
CONCLUSION: HRV in the supine position allowed identifying patients with syncope and cardioinhibitory response with a high negative predictive value and likelihood ratio of 5.8.

Entities:  

Mesh:

Year:  2016        PMID: 28558089      PMCID: PMC5210461          DOI: 10.5935/abc.20160177

Source DB:  PubMed          Journal:  Arq Bras Cardiol        ISSN: 0066-782X            Impact factor:   2.000


  33 in total

1.  2015 heart rhythm society expert consensus statement on the diagnosis and treatment of postural tachycardia syndrome, inappropriate sinus tachycardia, and vasovagal syncope.

Authors:  Robert S Sheldon; Blair P Grubb; Brian Olshansky; Win-Kuang Shen; Hugh Calkins; Michele Brignole; Satish R Raj; Andrew D Krahn; Carlos A Morillo; Julian M Stewart; Richard Sutton; Paola Sandroni; Karen J Friday; Denise Tessariol Hachul; Mitchell I Cohen; Dennis H Lau; Kenneth A Mayuga; Jeffrey P Moak; Roopinder K Sandhu; Khalil Kanjwal
Journal:  Heart Rhythm       Date:  2015-05-14       Impact factor: 6.343

2.  Power spectrum analysis of heart rate variability to assess the changes in sympathovagal balance during graded orthostatic tilt.

Authors:  N Montano; T G Ruscone; A Porta; F Lombardi; M Pagani; A Malliani
Journal:  Circulation       Date:  1994-10       Impact factor: 29.690

3.  Prognostic Value of a Very Prolonged Asystole during Head-Up Tilt Test.

Authors:  Maria Salomé Carvalho; Katya Reis Santos; Pedro Carmo; Diogo Cavaco; Leonor Parreira; Francisco Morgado; Pedro Adragão
Journal:  Pacing Clin Electrophysiol       Date:  2015-05-31       Impact factor: 1.976

4.  Safety and tolerability of an aggressive tilt table test protocol in the evaluation of patients with suspected neurocardiogenic syncope.

Authors:  S C Vlay; C Brodsky; L C Vlay
Journal:  Pacing Clin Electrophysiol       Date:  2000-04       Impact factor: 1.976

5.  A standardized education protocol significantly reduces traumatic injuries and syncope recurrence: an observational study in 316 patients with vasovagal syncope.

Authors:  M Ali Aydin; Kai Mortensen; Tushar V Salukhe; Iris Wilke; Michelle Ortak; Imke Drewitz; Boris Hoffmann; Kai Müllerleile; Arian Sultan; Helge Servatius; Daniel Steven; Yskert von Kodolitsch; Thomas Meinertz; Rodolfo Ventura; Stephan Willems
Journal:  Europace       Date:  2011-11-01       Impact factor: 5.214

6.  Sex-related differences in autonomic modulation of heart rate in middle-aged subjects.

Authors:  H V Huikuri; S M Pikkujämsä; K E Airaksinen; M J Ikäheimo; A O Rantala; H Kauma; M Lilja; Y A Kesäniemi
Journal:  Circulation       Date:  1996-07-15       Impact factor: 29.690

7.  Frequency of arrhythmic events during head-up tilt testing in patients with suspected neurocardiogenic syncope or presyncope.

Authors:  Phil Ho Kim; Seok Jin Ahn; June Soo Kim
Journal:  Am J Cardiol       Date:  2004-12-15       Impact factor: 2.778

8.  Persistence of muscle sympathetic nerve activity during vasovagal syncope.

Authors:  Gautam Vaddadi; Murray D Esler; Tye Dawood; Elisabeth Lambert
Journal:  Eur Heart J       Date:  2010-03-19       Impact factor: 29.983

Review 9.  Pathophysiology of neurally mediated syncope: Role of cardiac output and total peripheral resistance.

Authors:  Qi Fu; Benjamin D Levine
Journal:  Auton Neurosci       Date:  2014-07-16       Impact factor: 3.145

10.  Power spectral analysis of heart rate variability during graded head-up tilting in patients with vasodepressor syncope.

Authors:  M Prinz-Zaiss; A N Yeap; V Moguilevski; L Trigg; B P McGrath
Journal:  Clin Exp Pharmacol Physiol       Date:  1995 Jun-Jul       Impact factor: 2.557

View more
  3 in total

1.  Physical Vascular Therapy (BEMER) Affects Heart Rate Asymmetry in Patients With Coronary Heart Disease.

Authors:  Zita Kreska; Péter Mátrai; Balázs Nemeth; Bella Ajtay; István Kiss; László Hejjel; Zénó Ajtay
Journal:  In Vivo       Date:  2022 May-Jun       Impact factor: 2.406

2.  Frequent occurrence of postbreakfast syncope due to carotid sinus syndrome after surgery for hypopharyngeal cancer: A case report.

Authors:  Yuya Ando; Kenichi Hashimoto; Azusa Sano; Naoya Fujita; Rempei Yanagawa; Yosuke Ono; Yasuhiro Obuchi; Daisuke Tatsushima; Shun Watanabe; Masayuki Tomifuji; Yuji Tanaka
Journal:  Medicine (Baltimore)       Date:  2021-05-21       Impact factor: 1.817

3.  Simultaneous beat-to-beat heart rate and systolic blood pressure variability in patients with and without neurally mediated syncope.

Authors:  Amirhossein Akbarzadeh; Fariborz Akbarzadeh; Babak Kazemi
Journal:  J Cardiovasc Thorac Res       Date:  2022-06-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.